MLXIPL and metabolic dysfunction-associated steatotic liver disease: Of note, in human biopsies of patients with NASH, we measured reduced ChREBP mRNA levels as compared with patients with NAFLD, and the lower ChREBP mRNA levels in NASH may contribute to the reduction of ChREBP protein levels.